IRCT20230403057810N1 IRCT 2023-04-08 Shahid Beheshti University of Medical Sciences Comparing the effect of magnesium sulfate nebulizer and ipratropium bromide nebulizer in children with asthma Comparison of the effectiveness of magnesium sulfate nebulizer and ipratropium bromide in children with asthma attacks admitted to Masih Deneshvari Hospital in Tehran in 1402 2023-05-05 anticipated 50 Complete https://irct.ir/trial/69395 interventional Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: After obtaining consent from the patient or parents and obtaining permission from the ethics committee, the procedure is explained to the patients or parents, which includes comparing the effectiveness of magnesium sulfate nebulizer and ipratropium bromide, both of which are approved for the treatment of asthma attacks. Both drugs are in liquid and colorless form, and the patient does not know which drug he has received. 3 Magnesium sulfate nebulizer in asthma attack. Intervention 1: ّFirst intervention group: Magnesium sulfate nebulizer (magnesium sulfate 50%, 0.3 mL (150 mg) diluted with 2.2 mL of distilled water). Intervention 2: Second intervention group: Ipratropium bromide nebulizer based on standard dose for age according to GINA 2022 guidelines. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information